The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CCTG BR.34: A randomized trial of durvalumab and tremelimumab +/- platinum-based chemotherapy in patients with metastatic (Stage IV) squamous or nonsquamous non-small cell lung cancer (NSCLC).
 
Natasha B. Leighl
Consulting or Advisory Role - Xcovery
Research Funding - Array BioPharma (Inst); Guardant Health (Inst); Novartis (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Nektar; Roche
 
Scott Andrew Laurie
No Relationships to Disclose
 
Glenwood D. Goss
No Relationships to Disclose
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Pfizer; Roche; Sanofi/Regeneron
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Martin R. Stockler
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Tilray (Inst)
Travel, Accommodations, Expenses - Medivation/Pfizer
 
Ming Sound Tsao
Honoraria - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Merck; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Merck; Pfizer; Roche Canada; Takeda
Research Funding - AstraZeneca (Inst); Bayer (Inst); Merck Sharp & Dohme (Inst)
 
Swati Kulkarni
No Relationships to Disclose
 
Normand Blais
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche Canada; Sanofi
Research Funding - AstraZeneca (Inst)
 
Anil A. Joy
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; Mylan; Novartis Canada Pharmaceuticals Inc; Roche Belgium; Roche Canada
Travel, Accommodations, Expenses - Pfizer; Roche Canada
 
Mihaela Mates
Consulting or Advisory Role - Novartis
 
Punam Rana
No Relationships to Disclose
 
Sunil Yadav
No Relationships to Disclose
 
Craig Underhill
Research Funding - Bristol-Myers Squibb (Inst)
 
Christopher W. Lee
No Relationships to Disclose
 
Penelope Ann Bradbury
Honoraria - Abbvie; Lilly; Merck
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim
 
Andrea Hiltz
No Relationships to Disclose
 
Janet Dancey
Leadership - 3Ci
Honoraria - 3Ci
Consulting or Advisory Role - Roche Canada; Sanofi
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Keyue Ding
No Relationships to Disclose
 
Francisco Emilio Vera Badillo
No Relationships to Disclose